Blanket Purchase Agreement 36F79720D0067-36C26024A0006

Award Date 11/6/23
Last Date to Order 10/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for the supply of blood bank reagents. The contract, valued at up to $36,593.10, has an ultimate completion date of May 31, 2022 and was awarded on June 1, 2020. The BPA was established under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. Grifols, a global healthcare company, has...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Blanket Purchase Agreement (BPA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, to provide cost-per-test clinical laboratory analyzers and associated products and services. The $939,392.25 BPA covers the supply of in-vitro diagnostic testing equipment, reagents, and accessories through February 2030. The original solicitation sought to...
Grifols Diagnostic Solutions Inc. was awarded a blanket purchase agreement (BPA) under the Critical Analyzers, Laboratory Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The BPA has a potential value of $447,337.52 and period of performance through April 30, 2028. Under the BPA, Grifols will provide blood bank testing services to support healthcare programs for veterans in the Oakland, California region. A...
This federal Blanket Purchase Agreement (BPA) with a ceiling value of $100,933.45 was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Werfen USA LLC, a for-profit manufacturer of in vitro diagnostic equipment, reagents, and services. The BPA is issued under Werfen's General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and test kits. This contract does not have a set-aside designation....
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The contract, valued at $1,428,493.95, is for the delivery of laboratory reagents and supplies over a period ending June 30, 2025. The contract utilizes the Multiple Award Schedule (MAS) contracting vehicle and has a firm fixed price pricing structure. Werfen...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The single-award BPA, valued up to $6,000,000, provides the VA's Veterans Integrated Service Network 21 with access to Werfen's blood gas instruments, testing kits, and associated laboratory services over a 5-year period from April 2025 to...
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 to Quotient Biodiagnostics, Inc. as a multiple-award contract under the Invitro Diagnostics, Reagents, Test GSA Schedule. The BPA has a potential value of $30,000 and a period of performance through September 2028. The BPA aims to procure blood bank reagents for use by VA medical facilities. As a multiple-award contract, the BPA functions as an...
This is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The BPA, valued at $53,174.88, is for the delivery of blood bank reagents and quality control materials to support the VA's blood banking operations. Through this BPA, the VA is procuring essential in vitro...
The Blanket Purchase Agreement (BPA) contract awarded to Immucor Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) is intended to provide a reliable supply of critical medical supplies related to blood transfusion and transplantation testing. Immucor, a leading manufacturer of in vitro diagnostic reagents, instruments, and consumables, will deliver a variety of immunology reagents, test kits, and related products to support the VA's healthcare operations...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded a Blanket Purchase Agreement (BPA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $225,000 BPA, awarded on April 1, 2024 with an ultimate completion date of March 31, 2029, is to provide blood bank reagents in support of the VA's blood banking operations and healthcare services. The VA has also awarded two task orders under this BPA to...

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 20 to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit corporation, to provide an automated gel instrument and associated reagents for blood bank testing at the Portland VA Medical Center. The single-award BPA has a ceiling value of $94,176.32 and a base period from November 2023 to October 2024, with four one-year option periods. The BPA was established under Grifols' existing GSA Schedule 66-III contract for Critical Analyzers and Laboratory Equipment. The automated gel instrument must meet technical requirements including processing a minimum of 100 samples with minimal technician intervention and integrating with the laboratory information system. Reagents will be ordered on an as-needed basis using fixed annual prices. The primary NAICS code for this requirement is 325413 for in vitro diagnostic substance manufacturing.

This BPA supports the VA's mission to provide healthcare services to veterans through its network of medical centers and outpatient clinics. The requirement was competed on an unrestricted basis, with no set-aside designations. The place of performance is Oakland, California, and the contract is funded by the VA.

Generated 10/3/24, 9:06 AM